Novartis’ SMA Gene Therapy Treatment Approved by FDA, Priced at $2.125 Million May 25, 2019 Life Science
Trump administration to roll back health-care protections for transgender people May 24, 2019 Life Science
Joinn Labs to Acquire US-Based Biomere, a Pre-clinical CRO, for $27.3 Million May 23, 2019 Life Science
WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement May 22, 2019 Life Science
Jacobs Wins Contract to Provide Construction Phase Services for WuXi Biologics Biomanufacturing Facility May 22, 2019 Life Science
China News Weekly 111 – Beijing is more innovative than New York and London, report says May 22, 2019 Life Science, Technology
Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced Protein Design Technology in Cellular Therapy May 22, 2019 Life Science, Technology
Exuma Reports Positive Early Results from China Trial of Conditionally Active Biologics May 21, 2019 Life Science
